Showing results (1-10 of 415) with videos related to
Sort By:
Pageof 42
Frontiers in Bioscience (Scholar Edition)|January 4, 2011
Targeted antioxidant therapies in hyperglycemia-mediated endothelial dysfunctionJudy B de Haan, Mark E CooperThe Journal of Clinical Investigation|November 18, 2014
Limiting reductive stress for treating in-stent stenosis: the heart of the matter?Judy B de HaanCritical Care (London, England)|June 3, 2014
The ethical dimension in published animal research in critical care: the dark side of our moonOlivier Huet, Judy B de HaanAntioxidants (Basel, Switzerland)|November 27, 2025
Dysregulated Redox Signaling and Its Impact on Inflammatory Pathways, Mitochondrial Dysfunction, Autophagy and Cardiovascular DiseasesMehnaz Pervin, Judy B de HaanRedox Report : Communications in Free Radical Research|February 25, 2014
Combating oxidative stress in diabetic complications with Nrf2 activators: how much is too much?Sih Min Tan, Judy B de HaanArteriosclerosis, Thrombosis, and Vascular Biology|March 28, 2009
Site-specific antiatherogenic effect of the antioxidant ebselen in the diabetic apolipoprotein E-deficient mousePhyllis Chew, Derek Y C Yuen, Philip Koh, et al.Clinical Science (London, England : 1979)|January 20, 2022
Adverse renal effects of NLRP3 inflammasome inhibition by MCC950 in an interventional model of diabetic kidney diseaseJakob A Østergaard, Jay C Jha, Arpeeta Sharma, et al.International Journal of Vascular Medicine|October 21, 2011
Targeting endothelial dysfunction in vascular complications associated with diabetesArpeeta Sharma, Pascal N Bernatchez, Judy B de HaanExpert Review of Cardiovascular Therapy|March 7, 2012
Novel pathways and therapies in experimental diabetic atherosclerosisChristine Koulis, Judy B de Haan, Terri J AllenDiabetes|June 28, 2015
Direct Endothelial Nitric Oxide Synthase Activation Provides Atheroprotection in Diabetes-Accelerated AtherosclerosisArpeeta Sharma, Stephanie Sellers, Nada Stefanovic, et al.Pageof 42